Asthma progression: Can we and should we measure it?

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy  Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.
Allergen immunotherapy: A practice parameter third update
Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD 
High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,
Fatty acids, inflammation, and asthma
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Advances in pediatric asthma in 2011: Moving forward
Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Current application of exhaled nitric oxide in clinical practice
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Fatty acids, inflammation, and asthma
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Advancing asthma care: The glass is only half full!
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut
The Editors’ Choice Journal of Allergy and Clinical Immunology
The National Biome Initiative: An allergy perspective
Peter M. Wolfgram, MD, David B. Allen, MD 
Etiology of asthma exacerbations
Practice Notes from the AAAAI
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Phillip Lieberman, MD, Michael Tankersley, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
News & Notes Journal of Allergy and Clinical Immunology
What are the best outcome measurements for atopic eczema
The Editors' Choice Journal of Allergy and Clinical Immunology
The Editors’ Choice Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, David Golden, MD 
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Christian Hennig, MD, Christine Happle, MD, Gesine Hansen, MD 
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
What is an “eosinophilic phenotype” of asthma?
Cephalosporin Side Chain Cross-reactivity
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Personalized asthma therapy in blacks—the role of genetic ancestry
Autophagy: Nobel Prize 2016 and allergy and asthma research
News & Notes Journal of Allergy and Clinical Immunology
The Editors' Choice Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Geographic variability in childhood asthma prevalence in Chicago
New pathways for itching in patients with atopic dermatitis?
Prevention of food allergy: Beyond peanut
The Editors' Choice Journal of Allergy and Clinical Immunology
Risk of oral food challenges
The Editors' Choice Journal of Allergy and Clinical Immunology
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Practice Notes from the AAAI
The Editors' Choice Journal of Allergy and Clinical Immunology
A simulation model of building intervention impacts on indoor environmental quality, pediatric asthma, and costs  Maria Patricia Fabian, ScD, Gary Adamkiewicz,
The Editors' Choice Journal of Allergy and Clinical Immunology
Thunderstorm-related asthma attacks
Measles and immunomodulation
The Editors' Choice Journal of Allergy and Clinical Immunology
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Environmental factors and eosinophilic esophagitis
News & Notes Journal of Allergy and Clinical Immunology
The GILL study: Glycerin-induced local reactions in immunotherapy
Advances in pediatric asthma in 2007
Natural history of cow’s milk allergy
The Editors’ Choice Journal of Allergy and Clinical Immunology
Primary prevention of asthma and allergy
The Editors' Choice Journal of Allergy and Clinical Immunology
Chitinases and chitinase-like proteins in TH2 inflammation and asthma
Presentation transcript:

Asthma progression: Can we and should we measure it? Stanley J. Szefler, MD  Journal of Allergy and Clinical Immunology  Volume 121, Issue 3, Pages 598-600 (March 2008) DOI: 10.1016/j.jaci.2007.12.1192 Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 This picture depicts the 3 witches in Shakespeare's Macbeth conjuring up a brew of allergens, viruses, environmental pollutants, and genetics that might play a role in developing bad outcomes of asthma. The scene of Macbeth meeting with the witches is not unlike that of the clinician trying to listen to the many signals that might predict the future outcome in managing their asthmatic patients. Journal of Allergy and Clinical Immunology 2008 121, 598-600DOI: (10.1016/j.jaci.2007.12.1192) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions